Upcoming Webinar:Join our experts for discussion on ‘Re-inventing Finance: with Process, People & Technology’.
you are here: HomeNewsIndia

SGPC passes Rs 912 crore budget for FY 2021-22

SGPC chief Bibi Jagir Kaur said just like last year, there was a sharp decline in income due to the Covid-19 pandemic. She said the historical gurdwaras are expected to generate a revenue of about Rs 647.25 crore during 2021-22.

March 30, 2021 / 10:09 PM IST
Gurdwara Sri Guru Singh Sabha. (PC- YouTube)

Gurdwara Sri Guru Singh Sabha. (PC- YouTube)

The Shiromani Gurdwara Parbandhak Committee, an apex gurdwara body on Tuesday passed a Rs 912.59 crore budget for the financial year 2021-22. The approved budget projects a revenue earning of Rs 871.93 crore in 2021-22 with the expenditure expected to exceed the revenue by Rs 40.66 crore.

SGPC chief Bibi Jagir Kaur said just like last year, there was a sharp decline in income due to the Covid-19 pandemic. She said the historical gurdwaras are expected to generate a revenue of about Rs 647.25 crore during 2021-22.

Gurudwara Bangla Sahib opens 'India's biggest' kidney dialysis facility; to offer services for free

Similarly, the revenue from educational institutions this year would be Rs 189.17 crore and the expenditure would be Rs 223.18 crore. Kaur said Rs 14 crore has been earmarked in the budget to celebrate the 400th birth anniversary of Guru Tegh Bahadur.

A sum of Rs 27.31 crore has been set aside for 'Gurmat Vidyalayas', she said. The budget meeting was attended by 86 members, including the Golden Temple's head priest Giani Jagtar Singh, Akal Takht jathedar Giani Harpreet Singh, Takth Sri Kesgarh Sahib's jathedar Giani Raghbir Singh, and SGPC president Bibi Jagir Kaur.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show
The budget was presented by SGPC general secretary Bhagwant Singh Sialka.
PTI

stay updated

Get Daily News on your Browser
Sections